ReviewPatient related outcome measures2014

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.

Raquel Planas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.